Background and Aims: Low-density lipoprotein cholesterol (LDL-C) is widely estimated by Friedewald equation (FE) and Enzymatic test (ET)
, which are affected by several factors. The aim of this study was to observe the impact of diabetic lipid and glucose patterns on the correlation between FE LDL-C (F-LDL) and ET LDL-C (E-LDL) in patients with coronary artery disease (CAD).
Methods and Results:
A total of 8155 CAD patients were consecutively enrolled and their lipid profiles were measured. The impacts of triglyceride (TG), glycosylated hemoglobin A1c (HbA1c), and high-density lipoprotein cholesterol (HDL-C) on the correlation of F-LDL and E-LDL were examined. The difference value (DV) between F-LDL and E-LDL was compared using ANOVA test. The CAD patients with DM were elder and had higher body mass index, plasma TG compared with those without DM (P < .05 separately). In the whole population, F-LDL was lower than E-LDL but showed a high correlation with E-LDL (r = .970, P = .000). Moreover, as the TG concentrations increased, the DV increased accordingly but the correlation between F-LDL and E-LDL decreased (P < .01). The similar trend was also found in both DM and non-DM patients comparing with different TG groups. However, in patients with DM, there was no significant difference of DV in different HbA1c groups or HDL-C concentrations (P > .05).
Conclusion:
Although F-LDL might underestimate the value of LDL-C, the correlation between F-LDL and E-LDL was clinically acceptable (r = .97), suggesting the LDL-C values measured by two methods were similarly reliable in CAD patients with or without DM.
K E Y W O R D S
diabetes mellitus, enzymatic test, Friedewald equation, LDL-C, triglycerides most laboratories. The enzymatic test (ET), which means the selective solubilization method in this study, is the most common and costeffective of LDL-C measurement applied in most hospitals worldwide.
Friedewald equation (FE) is the most widely used for LDL-C estimation in most clinical studies, but unreliable in extreme lipid values, such as triglyceride (TG) > 4.5 mmol/L or LDL-C < 1.8 mmol/ L 5 ; and in non-fasting conditions. 6 Yet, the abnormalities in lipoprotein composition in patients with DM are characterized as elevated TG level. Thus, the assessment of LDL-C using FE may result in inaccuracies.
To our knowledge, few studies have paid attention to the reliability of FE on the patients with DM. Besides, ET is commonly used in DM, but few studies are available regarding the impact of diabetic lipid and glucose on the correlation between ET and FE. Moreover, as earlier as 1990s, Rubiés-Prat J and his colleagues 7 discovered that FE might be inaccurate in patients with DM. However, the number of the study population is not large enough. Therefore, in this study, we assessed the difference between FE and ET of LDL-C value in hospitalized patients with CAD, especially focused on the patients with DM.
| METHODS

| Study population
The cross-sectional study was approved the hospital's ethical review board (Fuwai Hospital and National centre for cardiovascular diseases, Beijing, China) and complied with the Helsinki Declaration. The informed written consent was obtained from each patient. 
| Laboratory measurements
The glycosylated hemoglobin A1c (HbA1c) and lipid profile were analyzed by the clinical chemistry department of Fuwai hospital. 
| Statistical analysis
The continuous variables were described as means with standard deviations (SD, for normally distributed variables) or as a median with interquartile range (for skewed variables), and compared using the one-way ANOVA and Wilcoxon rank sum test, respectively.
Categorical variables are described as frequency and percentages, and compared using chi-square test. To compare measured and calculated LDL-C levels, the difference value (DV) between F-LDL and E-LDL for each patient and the LDL-C mean [(E-LDL + F-LDL)/2] were derived. Pearson correlation was performed for E-LDL and F-LDL. In the subgroup analysis of difference value (DV) between E-LDL and F-LDL, one-way ANOVA test was used in comparing with different TG, HDL-C, and HbA1c groups. All statistical analyzes were performed using SPSS software (version 22, IBM SPSS Inc., USA). Statistical significance was defined as a two-sided P-value of < .05.
| RESULTS
The general characteristics of the 8155 patients were presented in Table 1 . The patients with DM were found elder and more overweight than the non-DM patients (P < .05, respectively). But there was no significant difference of gender and treatment of lipid-lowering drug between DM and non-DM patients. The mean levels of TC, HDL-C, E-LDL, and F-LDL were lower in the DM group than in the non-DM group. F-LDL was lower than E-LDL with the mean DV of with DM. However, the mean levels of TG were higher in the DM group than in the non-DM group (P < .05, respectively).
In the whole population, the DV in different TG groups were increased along with the TG concentration while the correlation between E-LDL and F-LDL was decreased as shown in Table 2 (P < .01).
The correlation between E-LDL and F-LDL was the highest in the TG ≤ 1.1 mmol/L group (Pearson correlation = 0.983, P < .01).
When stratified by LDL-C categories, the absolute differences between E-LDL and F-LDL were increased along with the LDL-C concentrations in both DM and non-DM patients. However, the differences value had no significant in LDL-C ≤ 1.4 mmol/L group and 1.41-1.8 mmol/L group (P > .05, Table 3 ).
In patients with DM , the similar trend of DV changes in different TG group was found in Table 4 . As the TG level increasing, the mean of DV increased from 0.12 to 0.52 mmol/L (P < .01), and the Pearson correlation decreased from 0.975 to 0.960. In CAD patients without DM, it also displayed the similar trend of DV changes in different TG group (Table 4) .
As comparing with the DV in different HbA1c level, there was no significant difference in the DM group and non-DM group (P > .05, Table 5 ). However, along with the increase of HbA1c, the Pearson correlation between E-LDL and F-LDL increased from 0.961 to 0.969. It was the opposite trend in the non-DM patients. As shown in Table 4 , the correlation between E-LDL and F-LDL decreased from 0.967 to 0.960 following the increase of HbA1c level.
In the different HDL-C group, the HDL-C ≤ 1 mmol/L group had the minimum of mean of DV in both DM (P = .49) and non-DM patients (P = .087), but there was no statistically significant difference.
The Pearson correlation increased along with the increase of HDL-C level in the DM patients, whereas in the non-DM patients, it showed the opposite trend of correlation (Table 6 ).
T A B L E 2 Comparison of difference between E-LDL and F-LDL in CAD patients according to TG concentration
| DISCUSSIONS
In the present study focusing on CAD patients whose TG ≤ 4.5 mmol/L, we found that the lipid profile of CAD patients with DM is characterized by increased TG level and decreased HDL-C level, which was different from those without DM and consisting with the previous studies. 9, 10 Moreover, the data indicated that the FE estimated LDL-C levels were lower than the values obtained by ET, but had high correlation with the ET generally. In addition, the difference between the two methods increased with the TG concentration but the correlation decreased. However, the HbA1c and HDL-C level had no effect on the difference of the two methods of LDL-C measurement in the DM and non-DM patients, suggesting that the both of the enzymatic method and FE could apply in CAD patients with TG ≤ 4.5 mmol/L.
The accuracy and reliability of LDL-C measurement is essential in clinical practice, because it is not only the most important independent risk factor of CAD especially in patients with DM but also the strongly emphasized target for dyslipidemia treatment. [11] [12] [13] [14] There are different methods of LDL-C measure. Among them, the enzymatic method of LDL-C measurement is the mainstream of clinical laboratory test with applicable accuracy and stability using in the majority of the world.
T A B L E 3 Comparison of difference between E-LDL and F-LDL in CAD patients with or without DM according to LDL-C concentration T A B L E 4 Comparison of difference between E-LDL and F-LDL in CAD patients combined with or without DM according to TG concentration
FE as the most widely applied method in clinical practice is recommended in several guidelines related to the therapy of dyslipidemia. 11, 12, 15, 16 It assumes the ration of the mass of TG to very low-density lipoprotein cholesterol (VLDL-C) to be relatively constant. 8 However, in the real world, the ratios are variable in different individuals leading to less accuracy of FE, especially in the population with TG > 4.5 mmol/L and non-fasting state. 8, 10, 17, 18 The dyslipidemia of DM is primarily characterized as high level of TG and low level of cholesterol, [19] [20] [21] which might imply the unreliability of FE applying in the patients.with DM Hirany S and Whiting M et al observed that FE in comparison with direct assay was underestimated the LDL-C level. 19, 20 Chaen et al revealed that the FE showed the divergence from direct method in Japanese patients with DM.
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Although several formulas were derived from different population in order to improve the accuracy and reliability of FE, they were not found to be the suitable replacements. [23] [24] [25] [26] [27] Based on the above findings, we enrolled the patients with angiographic proven CAD and investigated the correlation between E-LDL and F-LDL and the associated impact factors. Similar to the previous studies, [28] [29] [30] we found there was significant difference between the overall mean of E-LDL compared with F-LDL, and the FE underestimated the LDL-C in all TG ranges. We also found that the DV increased with the TG level and the correlation between E-LDL and F-LDL decreased in both DM and non-DM patients. However, HbA1c and HDL-C had no impact on the DV between F-LDL and E-LDL in both DM and non-DM patients.
With regard to the significance of the present study, following reasons may suggest the clinical importance for our study.
(1) Although two methods of LDL-C measurement are frequently used in the real world, while its reliability is a key concern, especially in the era of intensive lipid control and in the highest risk patients; However, to our knowledge, the comparison study on these two methods in CAD patients are less common or limited by small sample size; (2) In China,
there are a huge number of hospitals using only FE to estimate LDL-C, while there have been no studies systematically evaluated the reliable of F-LDL in a cross-sectional patients with CAD in China. Furthermore, there are no recommendations that address the impact of glucose and lipid patterns on F-LDL. Thereby, we desire to provide related data to guide the practice in the real world.
Our study firstly observed the impact of glucose status and HDL-C levels on the difference and correlation of E-LDL and F-LDL in patients with DM. Although, there was no significant difference of DV between the two methods compared with different HbA1c and HDL-C level.
The correlation between the two methods changed oppositely in patients with DM compared with patients with non-DM.
There are several limitations in the present study. First, we used E-LDL instead of β-quantification as the standard reference measurement. Second, this study is a cross-sectional study and on follow-up of the changes in lipid profile of the population is available. Third, the data were collected in single center. Therefore, further study is necessary to analyze the correlation of F-LDL and E-LDL in the large population.
In conclusion, the present study showed that the FE had high correlation of enzymatic method although it underestimated the LDL-C by 0.23 mmol/L. The TG level was the main impact factor of correlation between the two methods. It suggested the LDL-C values measured by two methods were similarly reliable in CAD patients with or without DM.
